Israeli R&D Team Claim To Be Near COVID-19 Vaccine
MIGAL Researchers Had Already Developed An Avian Coronavirus Vaccine
An Israeli research team has discovered a potential COVID-19 vaccine candidate as a by-product of an avian vaccine they were developing and one of the team’s leaders told Scrip they hope to start producing and testing it by May.
You may also be interested in...
Switzerland’s GeNeuro will study whether its monoclonal antibody temelimab can prevent long-COVID, after data for the first time linked activation of human endogenous retroviruses (HERVs) to the condition and its associated neurological symptoms.
Investors during Roche’s first-quarter update 21 April will be looking for guidance on the strong growth of biosimilar competition to its cancer mainstays and how this may be offset by the group’s pipeline.
Russian sovereign wealth fund and Sputnik V vaccine producer RDIF has teamed up with the country’s biggest bank to fund ‘home-grown’ tech and science-intensive start-ups.